Skip to content

Reactivities of endocannabinoids toward metal-induced amyloid-β aggregation and oxidative stress associated with Alzheimer's disease

2026 · Inorganic Chemistry Frontiers · Vol 13, pp. 7593-7612 · 0 citations

Abstract

Endocannabinoids are endogenous lipid-based signaling molecules that coexist in the synaptic cleft with key pathological factors of Alzheimer’s disease (AD), including metal ions, amyloid-β (Aβ), and reactive oxygen species (ROS)....

View source

Similar papers

Aug 2026

STINGing the brain: S-nitrosylation drives neuroinflammation in Alzheimer's disease.

It is demonstrated that S-nitrosylation of the cyclic GMP-AMP synthase (cGAS) stimulator of interferon genes (STING) pathway sustains pathological neuroinflammation in AD, identifying a promising therapeutic target for this devastating disease.

A. A. Pieper, Emiko Miller, O. Khalimonchuk et al. · 0 citations
Open access Oct 2026

Chronic Inhalation of Sulphureous Water Mitigates Early Amyloid Pathology and Associated Microglial Changes in 5XFAD Mice

Background: Alzheimer’s disease (AD) is a chronic neurodegenerative disorder characterized by progressive cognitive decline and behavioral impairments. Hydrogen sulfide (H2S) is an endogenous gasotransmitter that exerts pleiotropic neuromodulatory, anti-inflammatory, cytoprotective, and trophic effects within the centr...

Martina Bodria, Eleonora Daini, Stefano Pioli et al. · 0 citations
Review Aug 2026

Peroxynitrite: A Potential Therapeutic Target for Alzheimer's Disease.

The pathogenesis of Alzheimer's disease (AD) involves multiple pathological processes, including β-amyloid (Aβ) deposition, aberrant tau modification, oxidative stress, and neuroinflammation. The molecular interaction mechanism among them remains to be further clarified. Peroxynitrite (ONOO⁻) is a potent oxidizing and...

Wei-Zhen Liu, Zheng-ji Piao, Tian-Li Zhu et al. · 0 citations
2026

Unravelling Erucin-Protein Binding Interactions through Multi-Spectroscopic and Molecular Docking Approaches: Mechanistic Perspectives on Antiglycation Activity

The antiglycation potential of 4-(methylthio)butyl isothiocyanate (4-MTBITC, Erucin) is compared with that of 4-(methylthio)butyl isothiocyanate (4-MTBITC, Erucin) to explore the potential of this compound as an antiglycation agent for diabetic complications.

Nakul Bhardwaj, Omish Sethi, Naincy et al. · 0 citations
Open access Sep 2026

Transcriptional modulation of β-Secretase ameliorates amyloid pathology and cognitive deficits in Alzheimer’s disease models

its pleiotropic pharmacology, CHX should be regarded here as a nonselective pharmacological probe rather than a repurposing-ready AD therapeutic. That said, the effect does not appear to be simply broad, nonspeci fi c suppression. Components of the γ -secretase complex were unchanged by CHX, and the reduction in gliosis...

Jinsu Park, H. Bae, Yoonsuk Cho et al. · 0 citations
Open access Sep 2026

TMEM59 regulates microglial Aβ phagocytosis in a TREM2‐dependent manner and acts as a potential therapeutic target for Aβ amyloidosis

Microglia‐mediated clearance of amyloid beta (Aβ) is crucial for mitigating Alzheimer's disease (AD) progression, yet the molecular regulators of microglial phagocytosis remain incompletely understood.

Jian Meng, Yong Wang, Jing-Hui Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.